Atika Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Atika Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49	Closed	-$1.08M	–	66
2025 Q4	$1.08M	Hold	49	–	–	0.11%	75
2025 Q3	$469K	Buy	+49	New	+$3.13K	0.04%	85

Atika Capital Management's CDTX Position: Q4 2025 in Review

Atika Capital Management sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 157,320 shares — an estimated $25.4M sold.

Atika Capital Management first reported a position in CDTX in Q3 2025 and held it in 1 quarter. The position peaked at $15.1M in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

Atika Capital Management reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
Atika Capital Management sold 157,320 Cidara Therapeutics shares in Q4 2025, an estimated $25.4M.
Atika Capital Management first reported a position in Cidara Therapeutics in Q3 2025 and held it in 1 quarter.
Atika Capital Management's Cidara Therapeutics position peaked at $15.1M in Q3 2025.
255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on Atika Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.